MCAM and breast carcinoma: The direct effect of CD146 on tumor growth has been demonstrated in several studies using genetic inactivation or inhibition with anti-CD146 blocking antibodies in breast cancer [20], neuroblastoma [24] and melanoma [22, 23, 25].